The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Schizophrenia and Nicotine Use: Report of a Pilot Smoking Cessation Program and Review of Neurobiological and Clinical Issues
Abstract
Nicotine use is a major public health problem that increases medical morbidity and mortality. Nicotine's action and the pathobiology of schizophrenic disorders have common neurobiological substrates. Tobacco smoking alters medication blood levels and effectiveness, modifies psychiatric symptoms, and is a clue for other substance abuse. This article presents an evaluation of a smoking cessation program for 24 smokers with schizophrenia. Fifty percent completed the program, 40 percent decreased use by 50 percent, and 13 percent remained abstinent (carbon monoxide verified) for 6 months. Nicotine replacement, motivational enhancement therapy, and relapse prevention behavioral therapy were important components of treatment. Pharmacotherapy strategies of a higher-dose nicotine patch, combining nicotine gum and a patch, and augmentation medication to nicotine replacement should be evaluated in future studies in this population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stages and processes of self-change of smoking: Toward an integrative model of change.
Prochaska, J. O., & DiClemente, C. C. (1983) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.51.3.390 · Cited by 9,098
(1991) · Medical Entomology and Zoology · Cited by 4,438
Clozapine for the Treatment-Resistant Schizophrenic: A Double-blind Comparison With Chlorpromazine
Kane, J. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800330013001 · Cited by 4,156
DSM-IV: Diagnostic and Statistical Manual of Mental Disorders
Bell, C. C. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03520100096046 · Cited by 2,610
Van Tol, H. H. M., Bunzow, J. R., Guan, H.-C., Sunahara, R. K., Seeman, P., Niznik, H. B., & Civelli, O. (1991) · Nature · doi:10.1038/350610a0 · Cited by 2,014
Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors
McGehee, D. S., Heath, M. J. S., Gelber, S., Devay, P., & Role, L. W. (1995) · Science · doi:10.1126/science.7569895 · Cited by 1,070
Prevalence of smoking among psychiatric outpatients
(1986) · American Journal of Psychiatry · doi:10.1176/ajp.143.8.993 · Cited by 1,058 · cited 4×
“…in the United States who are regular tobacco smokers, psychiatric patients are two to three times more likely to develop and maintain a nicotine addiction (Hughes et al. 1986; Goff et al. 1992; Lohr and Flynn 1992; Glassman 1993; MacKenzie et al. 1994; Ziedonis et al. 1994; Dalack et al. 1996).”
BackgroundInfluentialCHOUINARD, G., JONES, B., REMINGTON, G., BLOOM, D., ADDINGTON, D., MacEWAN, G. W., LABELLE, A., BEAUCLAIR, L., & ARNOTT, W. (1993) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199302000-00004 · Cited by 876
The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine
Corrigall, W. A., Franklin, K. B. J., Coen, K. M., & Clarke, P. B. S. (1992) · Psychopharmacology · doi:10.1007/bf02245149 · Cited by 829
Cigarette smoking: implications for psychiatric illness
(1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.4.546 · Cited by 723
Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats
Imperato, A., Mulas, A., & Di Chiara, G. (1986) · European Journal of Pharmacology · doi:10.1016/0014-2999(86)90629-1 · Cited by 693
Normalization of auditory physiology by cigarette smoking in schizophrenic patients
(1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.12.1856 · Cited by 679
Inhibition of monoamine oxidase B in the brains of smokers
Fowler, J. S., Volkow, N. D., Wang, G.-J., Pappas, N., Logan, J., MacGregor, R., Alexoff, D., Shea, C., Schlyer, D., Wolf, A. P., et al. (1996) · Nature · doi:10.1038/379733a0 · Cited by 656
Molecular and cellular aspects of nicotine abuse
Dani, J. A., & Heinemann, S. (1996) · Neuron · doi:10.1016/s0896-6273(00)80112-9 · Cited by 605
Cigarette smoking in schizophrenia: relationship to psychopathology and medication side effects
(1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.9.1189 · Cited by 579
The Human Costs of Tobacco Use
Bartecchi, C. E., MacKenzie, T. D., & Schrier, R. W. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403313301307 · Cited by 534
Clarke, P. B. S., & Pert, A. (1985) · Brain Research · doi:10.1016/0006-8993(85)90456-1 · Cited by 527
Spencer, D. D., Robbins, R. J., Naftolin, F., Marek, K. L., Vollmer, T., Leranth, C., Roth, R. H., Price, L. H., Gjedde, A., Bunney, B. S., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199211263272201 · Cited by 501
Newer antidepressants and the cytochrome P450 system
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.3.311 · Cited by 482
Establishing a Nicotine Threshold for Addiction -- The Implications for Tobacco Regulation
Benowitz, N. L., & Henningfield, J. E. (1994) · New England Journal of Medicine · doi:10.1056/nejm199407143310212 · Cited by 466
Moghaddam, B., & Bunney, B. S. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb01230.x · Cited by 402
Psychiatric comorbidity of smoking and nicotine dependence
Breslau, N. (1995) · Behavior Genetics · doi:10.1007/bf02196920 · Cited by 391
LOHR, J., & FLYNN, K. (1992) · Schizophrenia Research · doi:10.1016/0920-9964(92)90024-y · Cited by 340
Nicotine Dependence and Schizophrenia
Ziedonis, D. M., Kosten, T. R., Glazer, W. M., & Frances, R. J. (1994) · Psychiatric Services · doi:10.1176/ps.45.3.204 · Cited by 302
Self-citationCigarette smoking and Parkinson's disease
Baron, J. A. (1986) · Neurology · doi:10.1212/wnl.36.11.1490 · Cited by 291
Preferential stimulation of ventral tegmental area dopaminergic neurons by nicotine
Mereu, G., Yoon, K.-W. P., Boi, V., Gessa, G. L., Naes, L., & Westfall, T. C. (1987) · European Journal of Pharmacology · doi:10.1016/0014-2999(87)90556-5 · Cited by 273
LEOPOLD, I. H. (1951) · Archives of Ophthalmology · doi:10.1001/archopht.1951.01700020165008 · Cited by 222
Heath, A. C., & Martin, N. G. (1993) · Addictive Behaviors · doi:10.1016/0306-4603(93)90005-t · Cited by 212
D2 dopamine receptor gene and cigarette smoking: A reward gene?
Noble, E. P., Jeor, S. T. S., Ritchie, T., Syndulko, K., Jeor, S. C. S., Fitch, R. J., Brunner, R. L., & Sparkes, R. S. (1994) · Medical Hypotheses · doi:10.1016/0306-9877(94)90127-9 · Cited by 209
Clozapine decreases smoking in patients with chronic schizophrenia
McEvoy, J., Freudenreich, O., McGee, M., Vanderzwaag, C., Levin, E., & Rose, J. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(94)00365-a · Cited by 195
Hasegawa, M., Gutierrez-Esteinou, R., Way, L. E., & Meltzer, H. Y. (1993) · PubMed · Cited by 189
Effects of clozapine on smoking in chronic schizophrenic outpatients.
George, T. P., Sernyak, M. J., Ziedonis, D. M., & Woods, S. W. (1995) · PubMed · Cited by 179
Self-citationNicotine Dependence, Midbrain Dopamine Systems and Psychiatric Disorders
Nisell, M., Nomikos, G. G., & Svensson, T. H. (1995) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1995.tb00123.x · Cited by 166
Buckley, P. F., Thompson, P., Way, L. E., & Meltzer, H. Y. (1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.3.385 · Cited by 148
Nicotine and the central nervous system: Biobehavioral effects of cigarette smoking
Pomerleau, O. F. (1992) · The American Journal of Medicine · doi:10.1016/0002-9343(92)90619-m · Cited by 143
Neural mechanisms underlying nicotine dependence
Balfour, D. J. K. (1994) · Addiction · doi:10.1111/j.1360-0443.1994.tb03738.x · Cited by 142
Nicotine Addiction in Young People
Kessler, D. A. (1995) · New England Journal of Medicine · doi:10.1056/nejm199507203330311 · Cited by 133
Nicotine exposure and tardive dyskinesia
YASSA, R., Lal, S., Korpassy, A., & Ally, J. (1987) · Biological Psychiatry · doi:10.1016/0006-3223(87)90131-4 · Cited by 119
Smoking and movement disorders in psychiatric patients
Menza, M. A., Grossman, N., Horn, M. V., Cody, R., & Forman, N. (1991) · Biological Psychiatry · doi:10.1016/0006-3223(91)90163-g · Cited by 93
Decreased substance use in chronically psychotic patients treated with clozapine
Albanese, M., Khantzian, E. J., Murphy, S. L., et al. (1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.5.780b · Cited by 92
Tryptophan depletion and attenuation of cue-induced craving for cocaine
Satel, S. L., Krystal, J. H., Delgado, P. L., Kosten, T. R., & Charney, D. S. (1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.5.778 · Cited by 91
Polymorphisms of the D4 Dopamine Receptor Alleles in Chronic Alcoholism
George, S. R., Cheng, R., Nguyen, T., Israel, Y., & O’Dowd, B. F. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.2222 · Cited by 89
Possible effects of smoke-free inpatient units on psychiatric diagnosis and treatment.
Hughes, J. R. (1993) · PubMed · Cited by 88
The dopaminergic, glutamatergic, GABAergic bases for the action of amphetamine and cocaine
Karler, R., Calder, L. D., Thai, L. H., & Bedingfield, J. B. (1995) · Brain Research · doi:10.1016/0006-8993(94)01334-e · Cited by 71
Level of Functioning, Severity of Illness, and Smoking Status Among Chronic Psychiatric Patients
Hall, R. G., DUHAMEL, M., MCCLANAHAN, R., MILES, G., NASON, C., ROSEN, S., SCHILLER, P., TAO-YONENAGA, L., & Hall, S. M. (1995) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199507000-00008 · Cited by 68
Effects of subchronic nicotine administration on central dopaminergic mechanisms in the rat
Carr, L. A., Rowell, P. P., & Pierce, W. M. J. (1989) · Neurochemical Research · doi:10.1007/bf00964911 · Cited by 59
Smoking and tardive dyskinesia
Binder, R. L., Kazamatsuri, H., Nishimura, T., & McNiel, D. E. (1987) · Biological Psychiatry · doi:10.1016/0006-3223(87)90038-2 · Cited by 51
Vidal, C. (1994) · Drug Development Research · doi:10.1002/ddr.430310206 · Cited by 47
Clozapine attenuates cocaine conditioned place preference
Kosten, T. A., & Nestler, E. J. (1994) · Life Sciences · doi:10.1016/0024-3205(94)90084-1 · Cited by 46
Haloperidol Dosing Requirements: The Contribution of Smoking and Nonlinear Pharmacokinetics
Perry, P. J., Miller, D. D., Arndt, S. V., SMITH, D. A., & Holman, T. L. (1993) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199302000-00006 · Cited by 40
A clinical approach to help psychiatric patients with smoking cessation
Dalack, G. W., & Glassman, A. H. (1992) · Psychiatric Quarterly · doi:10.1007/bf01064680 · Cited by 25
Addiction to nicotine is due to high intrinsic levels of dopamine
Paulson, G. W. (1992) · Medical Hypotheses · doi:10.1016/0306-9877(92)90095-t · Cited by 21
Cited by
Smoking and Mental Illness: A Population-Based Prevalence Study
Lasser, K., Boyd, J. W., Woolhandler, S., Himmelstein, D. U., McCormick, D., & Bor, D. H. (2000) · JAMA · doi:10.1001/jama.284.20.2606 · Cited by 2,508
Jentsch, J. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00060-8 · Cited by 1,314
Causes of the excess mortality of schizophrenia
Brown, S., Inskip, H., & Barraclough, B. (2000) · British Journal of Psychiatry · doi:10.1192/bjp.177.3.212 · Cited by 1,087
Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health report
Ziedonis, D., Hitsman, B., Beckham, J. C., Zvolensky, M., Adler, L. E., Audrain-McGovern, J., Breslau, N., Brown, R. A., George, T. P., Williams, J., et al. (2008) · Nicotine & Tobacco Research · doi:10.1080/14622200802443569 · Cited by 735
Self-citationCo‐Morbidity of Smoking in Patients with Psychiatric and Substance Use Disorders
Kalman, D., Morissette, S. B., & George, T. P. (2005) · The American Journal on Addictions · doi:10.1080/10550490590924728 · Cited by 594
Self-citation
Metadata
- Authors
- Ziedonis, D. M., & George, T. P.
- Venue
- Schizophrenia Bulletin
- Publisher
- Oxford University Press (OUP)
- Published
- 1997-01-01
- Volume
- 23
- Issue
- 2
- Pages
- 247-254
- ISSN
- 0586-7614 (ISSN-L)
- 1745-1701
- OpenAlex
- W1966166215
- Cited by
- 278
- References
- 52
- FWCI
- 6.70
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.